These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34243632)

  • 21. Does Pioglitazone Lead to Neutrophil Extracellular Traps Formation in Chronic Granulomatous Disease Patients?
    Hule GP; Bargir UA; Kulkarni M; Kambli P; Taur P; Desai M; Madkaikar MR
    Front Immunol; 2019; 10():1739. PubMed ID: 31428088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress.
    Khasabova IA; Khasabov SG; Olson JK; Uhelski ML; Kim AH; Albino-Ramírez AM; Wagner CL; Seybold VS; Simone DA
    Pain; 2019 Mar; 160(3):688-701. PubMed ID: 30507781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of PPARγ on oxidative stress in diabetes-related dry eye.
    Wang J; Chen S; Zhao X; Guo Q; Yang R; Zhang C; Huang Y; Ma L; Zhao S
    Exp Eye Res; 2023 Jun; 231():109498. PubMed ID: 37169280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of peroxisome proliferator activated receptors (PPAR)-γ and -α agonists on cochlear protection from oxidative stress.
    Sekulic-Jablanovic M; Petkovic V; Wright MB; Kucharava K; Huerzeler N; Levano S; Brand Y; Leitmeyer K; Glutz A; Bausch A; Bodmer D
    PLoS One; 2017; 12(11):e0188596. PubMed ID: 29182629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
    Shim J; Kim BH; Kim YI; Kim KY; Hwangbo Y; Jang JY; Dong SH; Kim HJ; Chang YW; Chang R
    Int J Oncol; 2010 Jan; 36(1):223-31. PubMed ID: 19956851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excavatolide B inhibits nonsmall cell lung cancer proliferation by altering peroxisome proliferator activated receptor gamma expression and PTEN/AKT/NF-Kβ expression.
    Velmurugan BK; Yang HH; Sung PJ; Weng CF
    Environ Toxicol; 2017 Jan; 32(1):290-301. PubMed ID: 26790859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rosiglitazone Suppresses Calcium Oxalate Crystal Binding and Oxalate-Induced Oxidative Stress in Renal Epithelial Cells by Promoting PPAR-
    Liu YD; Yu SL; Wang R; Liu JN; Jin YS; Li YF; An RH
    Oxid Med Cell Longev; 2019; 2019():4826525. PubMed ID: 31781338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double antioxidant activities of rosiglitazone against high glucose-induced oxidative stress in hepatocyte.
    Wang X; Wang Z; Liu JZ; Hu JX; Chen HL; Li WL; Hai CX
    Toxicol In Vitro; 2011 Jun; 25(4):839-47. PubMed ID: 21333731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) using Pioglitazone Decreases the Survival of Acute Promyelocytic Leukemia Cells through Up-Regulation of PTEN Expression.
    Esmaeili S; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Salari S; Gharehbaghian A; Hamidpour M; Bashash D
    Anticancer Agents Med Chem; 2021; 21(1):108-119. PubMed ID: 32807067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation.
    Kim KY; Ahn JH; Cheon HG
    Mol Pharmacol; 2007 Sep; 72(3):674-85. PubMed ID: 17535976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiazolidinediones are potent inducers of fibroblast growth factor 21 expression in the liver.
    Oishi K; Tomita T
    Biol Pharm Bull; 2011; 34(7):1120-1. PubMed ID: 21720023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticancer effect of Limonin against benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice and the inhibition of A549 cell proliferation through apoptotic pathway.
    Gong C; Qi L; Huo Y; Zhang S; Ning X; Bai L; Wang Z
    J Biochem Mol Toxicol; 2019 Dec; 33(12):e22374. PubMed ID: 31702096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined treatment with peroxisome proliferator-activated receptor (PPAR) gamma ligands and gamma radiation induces apoptosis by PPARγ-independent up-regulation of reactive oxygen species-induced deoxyribonucleic acid damage signals in non-small cell lung cancer cells.
    Han EJ; Im CN; Park SH; Moon EY; Hong SH
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e239-48. PubMed ID: 23332223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pioglitazone attenuates aging-related disorders in aged apolipoprotein E deficient mice.
    Shen D; Li H; Zhou R; Liu MJ; Yu H; Wu DF
    Exp Gerontol; 2018 Feb; 102():101-108. PubMed ID: 29221940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis.
    Nakata S; Yoshida T; Shiraishi T; Horinaka M; Kouhara J; Wakada M; Sakai T
    Mol Cancer Ther; 2006 Jul; 5(7):1827-35. PubMed ID: 16891469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pioglitazone inhibits cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPARγ-independent pathway.
    Tsubaki M; Takeda T; Tomonari Y; Kawashima K; Itoh T; Imano M; Satou T; Nishida S
    J Cell Physiol; 2018 Apr; 233(4):3638-3647. PubMed ID: 29030979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Glitazones protects beta cell function from cytotoxic cytokines through PPAR gamma-dependent mechanisms].
    Li X; Wang AP; Yan X; Huang G; Liu BL; Zhou ZG
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1530-3. PubMed ID: 20650758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pioglitazone Modulates the Vascular Contractility in Hypertension by Interference with ET-1 Pathway.
    Palacios-Ramírez R; Hernanz R; Martín A; Pérez-Girón JV; Barrús MT; González-Carnicero Z; Aguado A; Jaisser F; Briones AM; Salaices M; Alonso MJ
    Sci Rep; 2019 Nov; 9(1):16461. PubMed ID: 31712626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
    Sommer M; Wolf G
    Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.